These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients. Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355 [TBL] [Abstract][Full Text] [Related]
43. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733 [TBL] [Abstract][Full Text] [Related]
44. G protein-coupled estrogen receptor protects from atherosclerosis. Meyer MR; Fredette NC; Howard TA; Hu C; Ramesh C; Daniel C; Amann K; Arterburn JB; Barton M; Prossnitz ER Sci Rep; 2014 Dec; 4():7564. PubMed ID: 25532911 [TBL] [Abstract][Full Text] [Related]
45. The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries. Yu X; Stallone JN; Heaps CL; Han G PLoS One; 2018; 13(1):e0191418. PubMed ID: 29360846 [TBL] [Abstract][Full Text] [Related]
46. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559 [TBL] [Abstract][Full Text] [Related]
47. Epileptogenic effects of G protein-coupled estrogen receptor 1 in the rat pentylenetetrazole kindling model of epilepsy. Kurt AH; Bosnak M; Inan SY; Celik A; Uremis MM Pharmacol Rep; 2016 Feb; 68(1):66-70. PubMed ID: 26721354 [TBL] [Abstract][Full Text] [Related]
48. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells. Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344 [TBL] [Abstract][Full Text] [Related]
49. Assessment of cell line competence for studies of pharmacological GPR30 modulation. Sousa C; Ribeiro M; Rufino AT; Leitão AJ; Mendes AF J Recept Signal Transduct Res; 2017 Apr; 37(2):181-188. PubMed ID: 27401115 [TBL] [Abstract][Full Text] [Related]
50. Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway. Ma HR; Wang J; Chen YF; Chen H; Wang WS; Aisa HA Int J Mol Med; 2014 Jun; 33(6):1627-34. PubMed ID: 24718680 [TBL] [Abstract][Full Text] [Related]
51. Acacetin improves endothelial dysfunction and aortic fibrosis in insulin-resistant SHR rats by estrogen receptors. Wei Y; Yuan P; Zhang Q; Fu Y; Hou Y; Gao L; Zheng X; Feng W Mol Biol Rep; 2020 Sep; 47(9):6899-6918. PubMed ID: 32892299 [TBL] [Abstract][Full Text] [Related]
52. Activation of the GPR30 receptor promotes lordosis in female mice. Anchan D; Gafur A; Sano K; Ogawa S; Vasudevan N Neuroendocrinology; 2014; 100(1):71-80. PubMed ID: 25012534 [TBL] [Abstract][Full Text] [Related]
53. G-protein-coupled estrogen receptor 1 is anatomically positioned to modulate synaptic plasticity in the mouse hippocampus. Waters EM; Thompson LI; Patel P; Gonzales AD; Ye HZ; Filardo EJ; Clegg DJ; Gorecka J; Akama KT; McEwen BS; Milner TA J Neurosci; 2015 Feb; 35(6):2384-97. PubMed ID: 25673833 [TBL] [Abstract][Full Text] [Related]
55. Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1. Bourque M; Morissette M; Di Paolo T Neuropharmacology; 2015 Aug; 95():343-52. PubMed ID: 25892506 [TBL] [Abstract][Full Text] [Related]
56. Activation of G protein-coupled estrogen receptor 1 mimics, but does not mediate, the anti-proliferative action of estradiol on pituitary lactotrophs in primary culture. Mitsui T; Ishida M; Izawa M; Arita J Endocr J; 2017 Jan; 64(1):103-115. PubMed ID: 27760898 [TBL] [Abstract][Full Text] [Related]
57. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion. Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837 [TBL] [Abstract][Full Text] [Related]
58. Angiotensin II induces microtubule reorganization mediated by a deacetylase SIRT2 in endothelial cells. Hashimoto-Komatsu A; Hirase T; Asaka M; Node K Hypertens Res; 2011 Aug; 34(8):949-56. PubMed ID: 21677656 [TBL] [Abstract][Full Text] [Related]
59. Low-concentration BPF induced cell biological responses by the ERα and GPER1-mediated signaling pathways in MCF-7 breast cancer cells. Lei B; Huang Y; Liu Y; Xu J; Sun S; Zhang X; Xu G; Wu M; Yu Y; Feng C Ecotoxicol Environ Saf; 2018 Dec; 165():144-152. PubMed ID: 30195206 [TBL] [Abstract][Full Text] [Related]
60. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1. Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]